drugset

drugset / Trial / NCT00141375

To Evaluate Long-Term Safety and Efficacy of Pregabalin in the Treatment of Neuropathic Pain After Spinal Cord Injury.

NCT00141375 ↗

Phase 3 Completed 132 enrolled Pfizer

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To evaluate long-term safety and efficacy of pregabalin in the treatment of neuropathic pain after spinal cord injury.

Timeline

Start: 2002-08
Primary completion: —
Completion: 2006-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pregabalin	Small molecule	—	—

Indications